Apr. 25, 2026
WHITE BEAR LAKE, MINNESOTA — Envoy Medical, Inc. (NASDAQ: COCH) announced that all 56 participants enrolled in its pivotal clinical trial evaluating the fully implanted Acclaim® cochlear implant have completed their activation visits, marking a key milestone in the study timeline. The activation visit represents the point at which each participant’s device is turned on for the first time. “With
















